谷歌浏览器插件
订阅小程序
在清言上使用

Treatment with Tucatinib in Addition to Pertuzumab and Trastuzumab in Patients with HER2-positive Metastatic Breast Cancer (HER2+MBC) after Local Therapy of Isolated Brain Progression: InTTercePT, a UCBG/GINECO Study

CANCER RESEARCH(2023)

引用 0|浏览29
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要